Anatomical location and number of injection sites of intravesical OnabotulinumtoxinA for females with refractory idiopathic overactive bladder: A scoping review
Neurourology and Urodynamics · 2024
DOI: 10.1002/nau.25392 ↗Kurz gefasst
Scoping Review in der Zeitschrift Neurourology and Urodynamics, 2024. Verfasst von Ellen Kelsey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urological Surgery, Barwon Health, University Hospital Geelong, Geelong, Victoria, Australia. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Urinary Bladder, Overactive, Vesico-Ureteral Reflux. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Western Alliance "Emerging Researchers".
Abstract (Originalsprache)
Aims
The negative impact on quality of life and the economic‐related burden to the patient and the health care system associated with idiopathic overactive bladder (iOAB) is well‐documented. Intradetrusor OnabotulinumtoxinA (BTN/A) injections are a well‐used treatment modality for the management of overactive detrusor refractory to medical management, with well‐documented efficacy and safety profiles. There is currently no best practice guideline for the administration of BTN/A for this procedure and historically the trigone of the bladder has been excluded from the injection paradigm given the risk of vesicoureteral reflux (VUR).
Methods
A scoping review methodology was employed to assess available literature to evaluate current techniques used. There is emerging literature that the inclusion of the trigone may increase the efficacy of the procedure, while maintaining a similar adverse effect profile. Similar results could also be obtained by decreasing the number of injection sites. A scoping review was completed with systematic methodology using the Preferred Systematic Reviews and Meta Analyses extension for Scoping Review checklist. The search strategy looked to evaluate BTN/A and number of injection sites and the inclusion of the trigone in female patients with iOAB. Studies with male or neurogenic bladder only were excluded. Mixed studies were included. A specialist research librarian was engaged, with supervision from a functional urologist using a combination of MeSH and natural language terms. Two investigators independently reviewed the titles and abstracts.
Results
Twelve articles were included and were published between 2005 and 2021. There was no evidence of VUR in any of the results. All but one study reported similar if not improved efficacy of trigone‐inclusion. Lower number of injection sites had similar efficacy profiles to higher numbers of intradetrusor injections.
Conclusions
Further high‐quality randomized control trials of trigone inclusion and reduction of injection sites are required. It is hoped that with further exploration of intraoperative methods for BTN/A injections, the development of universally accepted guidelines may optimize management and experiences for patients with iOAB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urological Surgery, Barwon Health, University Hospital Geelong, Geelong, Victoria, Australia.
- Department of Surgery, Deakin University, Geelong, Victoria, Australia.
Förderung
- Western Alliance "Emerging Researchers"
Zitieren
APA
Kelsey, E., Wynn, J., Holmes, A., & McLeod, K. (2024). Anatomical location and number of injection sites of intravesical OnabotulinumtoxinA for females with refractory idiopathic overactive bladder: A scoping review. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25392
Vancouver
Kelsey E, Wynn J, Holmes A, McLeod K. Anatomical location and number of injection sites of intravesical OnabotulinumtoxinA for females with refractory idiopathic overactive bladder: A scoping review. Neurourology and Urodynamics. 2024. doi:10.1002/nau.25392
BibTeX
@article{Kelsey2024,
author = {Kelsey, Ellen and Wynn, Jessica and Holmes, Angela and McLeod, Kathryn},
title = {Anatomical location and number of injection sites of intravesical OnabotulinumtoxinA for females with refractory idiopathic overactive bladder: A scoping review},
journal = {Neurourology and Urodynamics},
year = {2024},
doi = {10.1002/nau.25392}
}
EUVIMED